Core Insights - WELL Health Technologies Corp. reported record financial results for FY2025, achieving $1.40 billion in revenue and over $200 million in Adjusted EBITDA, marking significant growth compared to the previous year [2][3][5] - The company is focused on building a healthier Canada through its digital healthcare infrastructure, which includes various subsidiaries like WELLSTAR and HEALWELL [2][4] Financial Performance - Annual revenue for 2025 was $1.40 billion, a 52% increase from $919.7 million in 2024, driven by acquisitions and organic growth [5][12] - Adjusted EBITDA for 2025 reached $203.7 million, up 336% from $46.7 million in 2024, with an Adjusted EBITDA margin of 14.5% [5][12] - Canadian Patient Services revenue increased by 39% to $444.3 million, with Adjusted EBITDA rising 43% to $58.1 million [3][5] Operational Highlights - WELL achieved record Operating Free Cash Flow Attributable to Shareholders of $58.2 million in 2025, a 19% increase from $48.9 million in 2024 [3][5] - The company completed 19 clinic acquisition transactions in 2025, adding approximately $112.6 million in annualized clinical revenue [4][12] - Canadian Patient Services visits increased to 4.3 million, a 37% rise over the previous year, supported by both acquisitions and organic growth [12] Future Outlook - For 2026, WELL expects revenue guidance between $1.55 billion and $1.65 billion, with Adjusted EBITDA projected in the range of $175 million to $185 million [3][11] - The company plans to continue focusing on higher-margin primary care and diagnostics assets through its acquisition pipeline [4][11] - WELLSTAR is expected to be spun out to unlock value for shareholders, with management emphasizing the importance of this subsidiary in the digital healthcare landscape [4][11]

Company Overview - WELL Health Technologies Corp. is a digital healthcare company focused on improving health outcomes through technology, operating over 220 clinics and supporting more than 42,000 healthcare providers across Canada and the US [5][6] - WELLSTAR Technologies Corp., a majority-owned subsidiary of WELL, is a leading provider of interoperable technology solutions for healthcare providers in Canada [1][6] Upcoming Conference Participation - WELL and WELLSTAR will participate in the 2025 Cantech Investment Conference on October 9, 2025, in Toronto, Ontario [1][3] - The conference will feature presentations from WELL's CEO Hamed Shahbazi and WELLSTAR's CEO Amir Javidan, focusing on WELL's growth strategy and WELLSTAR's technological capabilities [2][3] Presentation Details - WELL's presentation is scheduled for 1:30 PM EST, while WELLSTAR's presentation will take place at 4:00 PM EST on the same day [3] - The conference is seen as an opportunity to highlight the companies' progress and build relationships with the investment community [3][4] Strategic Focus - WELL aims to reduce administrative burdens, increase provider efficiency, and improve patient care through the use of WELLSTAR and HEALWELL AI technologies [3][4] - The company emphasizes its role as the largest provider of outpatient services in Canada, showcasing its comprehensive healthcare and digital platform [5][6]